Lonza to Boost Biologics Sales With Manufacturing Facility Buy
Wall Street Journal
Lonza agreed to buy a manufacturing facility in the U.S. from Roche for around $1.2 billion in cash as it seeks to boost growth of its biologics division.
https://www.wsj.com/articles/lonza-to-buy-u-s-manufacturing-facility-from-roche-for-1-2-bln-40e656f6